News NHS braces for tough winter, saying budget falls short Cancer and A&E waiting times may not recover
News Future uncertain for Innate and BMS' troubled lirilumab Doubts over future of cancer immunotherapy
News Tesaro gets European approval on Zejula, set to challenge AZ Tesaro's PARP drug approved in wider ovarian cancer population
News Samsung Bioepis Herceptin biosimilar approved in EU Mylan and Biocon resolve biosimilar manufacturing issues
News Roche double trial success could expand use of two new drugs A double trial success from Roche sees it eyeing a combination therapy in lucrative first-line lung cancer, and wider use of its just-approved haemophilia drug, Hemlibra.
News FDA approves Roche potential haemophilia blockbuster Blood cancer drug Gazyva also gets new US use
News Pfizer targets $2.5bn more in cost savings Pfizer's second-quarter results update is headlined by news of an additional $2.5 billion in cost-cutting initiatives.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
